Benchmark Holdings is a leading aquaculture biotechnology company. Through our investment, we are enabling aquaculture producers to improve their sustainability and profitability by providing products and solutions in genetics, advanced nutrition and health which improve yield, quality and animal welfare. 

Focussing on salmon, shrimp, bass and bream, Benchmark is present in every major aquaculture market with customers in 70 countries.

Listed on the AIM market of the London Stock Exchange, Benchmark has a broad portfolio of products including sophisticated genetics which improve yield and disease resistance, advanced nutrition solutions which deliver growth and resilience, and sea lice treatments which are helping to address the biggest biological challenge in salmon production. 

Its breakthroughs include the adoption of human cancer cell screening techniques to enable earlier disease identification in aquaculture, reducing waste and antibiotic use.  

Find out more.

Grosvenor Food & AgTech is an ideal shareholder. Their knowledge of the aquaculture sector has been hugely helpful in focusing our offering.

Trond Williksen
Chief Executive Officer, Benchmark Holdings PLC